Invitation to LEUKEMIA 360 – Paris, November 13, 2025

Accelerating Innovation Together in Leukemia and Related Diseases.

Dear colleagues and innovation stakeholders,

After a successful launch last year, we are pleased to invite you to the 2^nd edition of LEUKEMIA 360, a major event taking place on November 13, 2025, in Paris, aimed at becoming the premier international meeting devoted to academia-industry leukemia R&D&I partnerships.

This unique forum will bring together academic experts (researchers, clinicians, and operational staff from 75 research teams), industry leaders and specialists, innovators, investors, and patient representatives, working in the field of leukemia and related diseases. The goal : to foster connections, stimulate collaborative R&D, and build strategic partnerships across the entire value chain — from the identification of novel therapeutic targets to industrial development.

In the face of ongoing unmet medical and industrial needs, LEUKEMIA 360, organized by OPALE Carnot Institute, The Organization for Partnerships in Leukemia, serves as a catalyst to accelerate innovation, together, and save more lives of adult and pediatric patients suffering of AML, ALL, MDS, MPN and other rare related disorders.

What to expect:

🔬 Cutting-edge scientific presentations
🚀Highlights of companies active in the leukemia field
🤝 Networking sessions and 1:1 meetings
🧑🏻‍🔬 R&D workshops with matter experts presenting their platforms
🌍 A collaborative perspective to connect the ecosystem’s players

Join us in Paris for the 2025 edition of LEUKEMIA 360 and be part of this collective momentum shaping tomorrow’s breakthroughs and accelerating therapeutic and diagnostic innovation in the field of leukemia and related diseases!